1 month - $33.00

4 months - $120.00
Save $12.00+
FREE S/H






Arthritis

The Media’s Focus on Prescription Pain Killers Ignores Natural Remedies for Preventing and Treating Arthritis
By Richard P. Huemer, MD

Novel Method Combats Chronic Inflammation
By Julius G. Goepp, MD

Boron
Crucial in Supporting Bones, Boron Also Preserves Joint Health and Cognitive Function

By Dan Harvey

 

Boswellia Inhibits 5-LOX

Native to Asia, the Boswellia serrata tree produces a gummy sap that traditional medical practitioners have used for inflammation and arthritis.

Sign Up For Our Free Email Newsletter
Name
Email

A key constituent of the sap is beta-boswellic acid, which scientists have found to be an effective inhibitor of the 5-LOX inflammatory enzyme.20 A standardized beta-boswellic acid preparation called 5-Loxin™, available in certain natural anti-inflammatory preparations, makes it possible to obtain the benefits of 5-LOX inhibition without consuming large quantities of ordinary boswellia extract.

Glucosamine Promotes Healthy Joints

The cartilage between joints acts as a shock absorber, protecting the bones and tissues from the impact creating during walking and other bodily movements.

Glycosamino-glycans are long, unbranched molecules of repeating pairs of sugars that help cushion the joints from wear and tear. These highly viscous molecules exist in the extracellular matrix, making them ideal as a lubricating fluid for the joints.

Glucosamine is a natural remedy that has been found to be useful in promoting healthy joints. Glucosamine is an amino sugar that is crucial for the construction of glycosaminoglycans in articular cartilage. Reduced glycosaminoglycans content in osteoarthritic cartilage matrix has been found to correlate with the severity of osteoarthritis. Oral glucosamine appears to promote the secretion of more glycosaminoglycans by chondrocytes. Clinically, glucosamine has demonstrated benefits in patients with arthritis of the hip or knee.38

Clinical evidence suggests that glucosamine helps maintain the joint space and may help rebuild damaged cartilage. By contrast, NSAIDs have a propensity to make cartilage deteriorate.39 Glucosamine also inhibits certain enzymes that destroy cartilage, including collagenase and phospholipase. By blocking pathogenic mechanisms that lead to joint degeneration, glucosamine delays the progression of osteoarthritis and relieves symptoms even for weeks after termination of the treatment.40

Glucosamine is becoming recognized as a treatment of choice for osteoarthritis. Its ability to repair and improve joint function, in addition to providing pain relief, gives it a significant advantage over conventional treatments. Additionally, glucosamine may stimulate new tissue growth and suppress the enzymes that otherwise break down cartilage.

Multiple Benefits of Methylsulfonylmethane

Methylsulfonylmethane is another natural remedy that may benefit individuals with arthritis. A naturally occurring, organic sulfur compound found in human diets and those of virtually all other vertebrates, methylsulfonylmethane is produced by the body as a result of the foods we eat. In vertebrates, the body’s concentration of methylsulfonylmethane decreases with age. Some research suggests a minimum concentration of methylsulfonylmethane must be maintained in the body to preserve normal function and structure.

In experiments using radiolabeled sulfur, it was shown that after ingestion, methylsulfonylmethane gives up its sulfur to the essential amino acids methionine, cysteine, and other serum proteins, eventually finding its way into the collagen of skin, joints, and blood vessels. It is also incorporated in the keratin of hair and nails.

Animal studies have shown that joints affected by osteoarthritis have lower sulfur content,41 and that arthritic mice given methylsulfonylmethane experience less joint degeneration.42 In a double-blind trial in people with osteoarthritis, subjects who received methylsulfonylmeth-ane experienced significant pain relief.43 Methylsulfonylmethane is known to be safe and nontoxic.

A small, uncontrolled study of arthritic women conducted by Stanley W. Jacob, MD, indicated that methylsulfonylmethane was as effective as ibuprofen, but without the latter’s side effects.44 Much of what we know about methylsulfonylmethane comes from Dr. Jacob’s 20 years of experience in the renowned DMSO Clinic at Oregon Health Sciences University. Methylsulfonylmethane is in fact a derivative of DMSO (dimethylsulfoxide), another powerful arthritis fighter.

Methylsulfonylmethane (MSM) is a small but highly effective molecule that inhibits pain impulses along nerve fibers, quells inflammation, increases blood supply, reduces muscle spasms, and softens scar tissue. Methylsulfonylmethane relieves pain and inflammation in osteoarthritis, rheumatoid arthritis, lupus, scleroderma, and fibromyalgia. It has also been reported to be helpful in allergies, back pain, headaches, temporomandibular joint dysfunction, tendonitis, and more. Most users take 1000-3000 mg daily, but some require more. Methylsulfonylmethane can be applied topically as well as taken orally.44

NUTRIENTS FOR HEALTHY JOINTS

Foods that are high in arachidonic acid and saturated fat, that rank high on the glycemic index (raising blood sugar quickly), and that have a low ratio of calcium to phosphorus are poor choices for arthritis sufferers.

Among the foods to eliminate or cut back on:
• Red meats and organ meats
• Fried foods
• Egg yolks
• White flour products (breads, rolls, cakes, cookies, donuts, etc.)
• White rice
• Soft drinks
• Fruit juices
• Sugary treats

These foods are recommended:
• Fresh vegetables and fruits
• Salmon and other oily fish
• Nuts and legumes
• Whole grains
• Low-fat or nonfat dairy products

* Some people with arthritis notice improvement from avoiding vegetables of the nightshade family, including tomatoes, potatoes, red and green peppers, and eggplant. Nutritionally oriented doctors sometimes recommend a diet consisting largely of raw foods for their more severely arthritic patients.

Synergistic Effects of Glucosamine, (MSM) Methylsulfonylmethane

In an exciting new study, the combination of glucosamine with methylsulfonylmethane was found to be more effective in improving the signs and symptoms of osteoarthritis than the use of either agent alone.45 Glucosamine is known as a chondroprotective agent since it helps to protect and restore joint cartilage. Methylsulfonylmethane is known to be an effective natural analgesic and anti-inflammatory.

In this study, 118 patients with mild to moderate osteoarthritis were treated three times daily for 12 weeks with either 500 mg of glucosamine, 500 mg of methylsulfonylmethane, a combination of both, or an inactive placebo. The patients were evaluated for pain, inflammation, and swelling at 0, 2, 4, 8, and 12 weeks.45

Glucosamine, methylsulfonylmethane, and the combination of glucosamine and methylsulfonylmethane significantly relieved the pain and swelling of osteoarthritis compared with placebo. After 12 weeks of treatment, the average pain score in the glucosamine-only group dropped from 1.74 to 0.65. In the methylsulfonylmethane-only group, the score fell from 1.53 to 0.74. In the group taking both glucosamine and methylsulfonylmethane, however, the average pain score dropped from 1.70 to 0.36. The researchers also found that the combination therapy had a faster effect on pain and inflammation than either glucosamine or methylsulfonylmethane alone.45 The study authors concluded that the combination of glucosamine with methylsulfonylmethane provides better and more rapid improvement in patients with osteoarthritis than either agent alone.

Practical Advice on Nutrients and Drugs

The nutritional management of arthritis goes far beyond the items discussed in this article. Additional nutrients important for those suffering with arthritis include vitamin C, antioxidants, B-complex vitamins, and trace minerals, especially selenium and copper. A healthy, natural diet is fundamental to managing inflammatory conditions such as arthritis (see the sidebar, “Nutrients for Healthy Joints”).

Nutritional and herbal remedies may offer a safe, effective first line of therapy for many arthritis sufferers. Natural remedies—including fish oil, boswellia, citrus flavonoids, glucosamine, and methylsulfonylmethane—have been found to effectively reduce inflammation and protect joint health. For those experiencing more severe arthritis that requires powerful drugs such as COX-2 inhibitors, nutritional and herbal agents used concomitantly may allow lower drug doses. A physician should be consulted when combining prescription drugs with natural remedies.

Prescription and over-the-counter medications are often the doctor’s first choice for treating pain and inflammation. Given the risks inherent in these drugs, as evidenced by the recent withdrawal of Vioxx® from the market, this may not be a safe or prudent choice. When nutritional substances like fish oil, boswellia, citrus flavonoids, glucosamine, and methylsulfonylmethane are used as a first line against arthritis pain, drugs can become a last resort. Some people will need drugs, but many others will find relief from pain and inflammation without the risk of toxic side effects.

For the past 16 years, green tea polyphenols have grabbed the headlines,1 but a related family of black tea compounds called theaflavins is capturing the attention of longevity researchers.

Theaflavins possess a unique ability to favorably influence human health by regulating genes that produce inflammatory cytokines and other toxic factors implicated in degenerative disease and aging. By modulating inflammation at its earliest stages, theaflavins represent a new tool in the fight against inflammation-related pathologies such as cancer, heart disease, senility, and arthritis.

Tea Extracts and Theaflavins

The past decade has seen a veritable explosion of data on the active components of tea.3 The flavonoid epigallocatechin gallate (EGCG) found in green tea is widely known for its disease-preventing capabilities,4 and now its sister molecules, the theaflavins, are beginning to share the spotlight. What has researchers particularly excited is how theaflavins exert their health-promoting benefits by favorably altering our genes. This phenomenon, known as “nutrigenomics,” will be fully explained in this article.

Theaflavin Inhibits Inflammation

Much of the misery of age-related conditions such as cardiovascular disease, diabetes, chronic pain, and even cancer can be laid at the feet of inflammatory processes that presumably originally evolved for the preservation of our health. A lifetime of exposure to oxidation and inflammatory stimuli leaves us awash in molecules known as cytokines and chemokines, which are used by immune system cells to signal each other and react to potential threats.

Long-term effects of these cytokines include increased tissue oxidation and further inflammation, which perpetuates the cycle and increases our risk for a myriad of chronic conditions. These inflammatory signaling molecules, of course, are the protein products of specific genes, and their production is regulated by transcription factors, as is all genetic activity in the body. Many nutrients help prevent or mitigate chronic disease either “upstream” in the process by preventing oxidation or “downstream” by inhibiting the effects of cytokines once produced. The remarkable ability of theaflavins to target specific gene transcription factors may allow for exquisite control of inflammation exactly when and where it starts—when inflammation-producing genes are “switched on” to start manufacturing cytokines.

Children’s health researchers at the University of Cincinnati described theaflavin’s novel anti-inflammatory characteristics in a 2004 paper,5 in which they identified the effect of varying concentrations of theaflavin on cells in a laboratory culture dish. The researchers were specifically interested in the gene that produces the inflammatory cytokine interleukin-8 (IL-8), which is responsible for much of the acute inflammation seen in conditions such as asthma, gum disease, and inflammatory bowel disease.6,7 Remarkably, theaflavin inhibited IL-8 production, even at very low concentrations. Even more remarkably, the effect was traced to theaflavin’s ability to inhibit the transcription of the IL-8 gene—in other words; theaflavin blocked the gene from actually expressing its product, the inflammatory cytokine.5 This pinpoint accuracy opens the door to many specific applications of theaflavin as an anti-inflammatory nutrigenomic agent.

Theaflavins—Working at the Genetic Level to Control Age-Related Disease

The first studies of theaflavins as modulators of genetic transcription began to appear at the turn of the present century, with recognition that theaflavins could control the expression of genes involved in cancer production, and a possible role in cancer chemoprevention as a result8,9 (remember that cancer, like heart disease, has direct connections with inflammation, particularly in its earliest stages).

By 2006, biologists in Iowa were already able to review the multiple sites at which theaflavins exert their gene-regulating effects: they (along with other polyphenols) up- or down-regulated production of enzymes involved in cancer production, they inhibited metastasis by blocking the effects of genes that produce enzymes making tissues more permeable to malignant cells, and they reduced the formation of new blood vessel growth needed for tumors to spread by blocking production of vascular endothelial growth factor, or VEGF. The review article concluded that green and black tea polyphenols act at numerous points regulating cancer cell growth, survival, and metastasis, including effects at the DNA, RNA, and protein levels.”1

Further studies have supported and expanded upon this work, progressively building the case for a specific group of theaflavin extracts from black tea.10 In 1999, biochemists in Taiwan investigated the effects of various tea components, including theaflavins, on induction of inflammatory molecules in mouse cells in culture.11 A group of four theaflavins was found to potently inhibit production of those inflammatory molecules.

In 2000, other scientists in the same group were able to demonstrate that these theaflavin extracts could reduce inflammatory cytokine production even in the face of stimulation by one of the most powerful inducers of inflammation known, a bacterial molecule called lipopolysaccharide (LPS).12 Importantly, this group also began the process of identifying the specific fractions, or groups of factors, in the theaflavin extracts that were the most powerfully active in blocking production of the inflammatory cytokines.

By 2002, these productive researchers had further extended their findings, demonstrating that the most active fractions of the theaflavin extracts could prevent inflammation on the skin and paws of mice that was induced experimentally with a toxic substance.13 Another Taiwanese researcher also published a 2002 report showing that the most active fraction of theaflavins was a potent cancer chemopreventive, chiefly through suppressing genes involved in tumor promotion and inflammation.14 In 2004, Japanese researchers were able to pin down platelet anti-aggregating effect to those same highly active fractions of theaflavins.15

Since 2005, the number of scholarly papers describing the powerful anti-inflammatory, anticancer, and longevity-enhancing qualities of these highly active theaflavin fractions has blossomed to several dozen studies, each providing more high-resolution details about just how these molecules act,16-20 and broadening their beneficial effects to prevention of ischemia-reperfusion injury following strokes,16,21 alcohol-induced pancreatitis,22 colitis,23 cigarette smoke-induced lung damage and cancers,24-26 cardiovascular disease,27 and even parasitic infection.28

What You Need to Know: Theaflavins
  • Inflammation is intimately involved in aging and the manifestations of age-related diseases—in fact, the two processes are so closely intertwined they have recently been dubbed inflammaging by an internationally recognized expert.

  • Many dietary approaches to countering the effects of inflammation are effective, but the emerging science of nutrigenomics offers insight into highly targeted nutritional supplements such as the theaflavin family of molecules extracted from black tea.

  • Theaflavins, like other nutrigenomically active molecules, exert their powerful effects by promoting activity of genes involved in controlling inflammation, and suppressing activity of genes involved in promoting inflammation.

  • Highly purified theaflavin extracts have been shown to reduce damage caused by inflammation-based diseases such as cancer, cardiovascular disease, diabetes, and other age-related conditions.

  • A human study of purified theaflavin extracts produced dramatic reduction in disease-causing mediators of inflammation, including levels of CRP. This effect has been directly associated with longevity.

Protecting Against Vascular Diseases

Evidence that tea confers health benefits is millennia-old, but the mechanisms by which it works have only recently been revealed. It is known from epidemiologic studies, for example, that drinking multiple cups of tea per day reduces low-density lipoprotein (LDL). Cardiologists at Vanderbilt University studied the impact of a theaflavin-enriched green tea extract on lipid profiles of subjects with mild-to-moderately elevated cholesterol.29 Studying 240 men and women in China, the researchers randomly assigned patients to receive either placebo or a theaflavin-enriched green tea extract (375 mg) daily for 12 weeks. At the end of the study, the theaflavin-supplemented patients experienced decreases in their total cholesterol by 11% and LDL by 16%. Placebo recipients had no change at all. No significant adverse effects were observed, and the researchers concluded that this theaflavin-enriched extract was “an effective adjunct to a low-saturated-fat diet.”

Boston cardiologists studied the impact of black tea and its theaflavin components supplementation on endothelial dysfunction30 in a study that randomly assigned 66 patients with coronary artery disease to consume either black tea or water. The study was designed in a “cross-over” fashion so that all subjects got both the tea and the water at different times (this allows comparisons within individuals as well as between subjects). The findings were dramatic: both short- and long-term tea consumption significantly improved blood flow in arteries, as detected by ultrasound measurements. This flow is controlled by endothelial cells and is typically decreased in patients with cardiovascular diseases. The researchers concluded that, “short- and long-term black tea consumption reverses endothelial vasomotor dysfunction in patients with coronary artery disease.”

In a British study of healthy men aged 18-55 years, subjects were given black tea or placebo for four weeks, and the effects on their platelet activation were measured. By the end of the study, the tea-drinking group had significantly fewer platelet “clumps,” or aggregates, than the placebo group.31

Nutrigenomics: Dietary Control of Genetic Expression

The laws of genetic inheritance were first described in the mid-19th century, and from that time practically until the present we’ve tended to think of specific genes as permanent fixtures of each individual—we get our genes from our parents and they define our traits, such as hair and eye color, etc. By the early 20th century it was clear that genes could specify, or “code for,” unhealthy traits as well, and we all learned about inherited diseases such as sickle cell anemia and cystic fibrosis in high school biology. But it has only been within the past two decades that we have come to understand just how dynamic our genes really are.

We now understand that while individual genes may be the simple equivalents of “blueprints” on our chromosomes that tell cells how to make the specific enzymes and other proteins that define us, those genes are under exquisite control by a host of complex and interrelated systems collectively called transcription factors. Transcription factors may be thought of as the general contractors that, depending on the body’s needs, “order” production of necessary products built according to the genetic blueprints. And transcription factors, it turns out, are themselves controlled by a host of molecular influences—including a growing number of specific nutrients. The study of how these nutrients work to control the genes’ production levels is called nutrigenomics.44 Well-known nutrigenomics molecules include, for example, the omega-3 fatty acids, which regulate lipid profiles,45 insulin responses,46 and inflammatory mediators,47 and the spice-derived curcumin molecule that shuts down transcription factors involved in inflammation and cancer production.48

In fact, according to acclaimed scientist Peter J. Gillies, PhD, “Nutrigenomics may provide the nutritional sciences with a molecular basis for positioning nutritional bioactives, functional foods, and designer diets to preemptively offset chronic disease.”44 Dr. Gillies goes on to note that, “With the expansion of research and the development of shared nutrigenomic databases, it may well become possible to define and track the influence of targeted nutrition on inflammation and the aging process.” In just the past two years, a host of other prestigious scientists have weighed in, supporting the pursuit of nutrigenomics as a vital framework for better understanding human biology and our relationship with our diets and our environments.2,43,49-56

Why was this study so significant? This study represented an important first step in understanding how tea components actually influence gene transcription, and therefore in understanding the role of tea components in nutrigenomic influences on health. Here’s how: platelets, the tiny cell fragments involved in blood clotting, stick together (aggregate) when activated in an important step in the cardiovascular disease process. The triggers for platelet activation include oxidative stress and inflammation, which cause transcription factors to increase the activity of genes making proteins involved in the aggregation process, acutely increasing cardiovascular disease risk.32-34

In other words, the British researchers had found that tea components must act as nutrigenomic factors, modulating production of these potentially lethal proteins. This groundbreaking finding led the way for further research investigating which tea components were responsible for it nutrigenomic activity and how to utilize theaflavin consumption to influence health and longevity.

Breaking News: Human Study With Highly Active Theaflavin Extracts

The studies listed above only begin to tell the theaflavin story—a similarly overwhelming body of literature supports their effectiveness in switching off the genes involved in virtually every cancer type,1,35,36 for example, as well as in modifying the way liver cells handle cholesterol and other fats.37 Of course, the most exciting news always has to do with human studies, and how any given supplement might benefit human health and preventing human disease. While there are numerous studies of the impact of tea drinking on the health of large human populations (epidemiologic studies), there are still no published studies on the effects of the specially purified, highly active theaflavin extracts we have been discussing. But late-breaking news is about to change that—with data too recent to have yet been published, a private company has revealed the outlines of a compelling human trial using just one such extract. Let us review what the company was able to share with us about this exciting, still-proprietary information, in advance of publication in a peer-reviewed journal.

The study was conducted in 2007 with 12 human volunteers. Eight of the subjects were supplemented with the highly purified theaflavin extract for one week, while four received placebo. At the end of the week, the subjects received injections of a bacterial cell membrane component called LPS, one of the most powerful stimulators of inflammation known to science. LPS in modest doses can induce shock, coma, and even death, so naturally these were only minute and safe doses, but clearly the volunteers were expected to show some evidence of acute inflammatory reactions. In addition to clinical monitoring, the investigators drew blood samples to monitor for early signs of inflammation, particularly those involving the “inducible” cytokines such as TNF-alpha, IL-6, IL-8, and C-reactive protein (CRP).38,39

Astonishingly, the supplemented subjects had a 56% reduction in levels of these cytokines even before they received the inflammatory challenge! Equally importantly, supplemented subjects experienced a 52% increase in levels of the protective, anti-inflammatory cytokine called IL-10,39 which is involved in prevention of viral respiratory infections, for example.40 The supplemented patients also demonstrated lower rates of production of the inflammation-generating transcription factor NF-kB (71%), the cytokine-generating enzyme COX -2 (72%), and the adhesion molecule ICAM-1.39

C-reactive protein rose dramatically as expected in the placebo recipients—this protein is a sensitive marker of acute inflammation, and chronically elevated levels of CRP are known to be a risk factor for advanced atherosclerosis. Remarkably, that elevation was 75% greater in the placebo group than in the theaflavin supplemented group.39

The ability of this highly active theaflavin extract to offset inflammatory cytokines points to a broad range of applications in human health in inflammatory conditions such as joint stiffness, muscle soreness, arthritis, osteoporosis, cardiovascular problems, diabetes, periodontal disease, and age-related immune dysfunction.

Pulling it All Together—How Theaflavins Promote Health and Longevity

There is a plethora of solid data on theaflavins’ nutrigenomic effects—modulating the activity of genes involved in the inflammatory cascade that leads to cancer, heart disease, diabetes, and other age-related conditions. But these are more than just numbers—reduction or control of those powerful genetic functions is likely to produce measurable results in individual humans. In fact, the term “inflammaging” has recently been coined by Professor Claudio Franceschi, a researcher in aging at the University of Bologna, to describe the inevitable accumulation of products of inflammation associated with advancing age.41 Modern risk-screening protocols aimed at identifying those at highest risk for early demise now routinely incorporate at least one measure of inflammation,42 and Professor Jose Ordovas of the Tufts University School of Graduate Biomedical Sciences has observed that “studies have established a ‘diet/genetic interaction’ that further modulates markers of inflammation, producing both positive and negative effects, depending on the net changes in gene expression.”43 Taken together, these researchers’ comments suggest that dietary interventions to reduce inflammation will enhance health, prevent disease, and ultimately promote longevity and quality of life. The highly purified theaflavins now available as supplements, with their targeted, nutrigenomics mechanisms of action, certainly deserve a place in any responsible, scientifically based program of preventive health maintenance.

Boron

Standard medical advice for people with osteoporosis is to take a calcium supplement with vitamin D, and often a bisphosphonate drug such as Fosamax® or Actonel®. Even with this advice, incidences of osteoporosis are soaring. Aging adults continue to suffer lethal fractures and diminished bone strength. Unfortunately, standard medical advice alone might not be sufficient to stem the devastating erosion of bone mass that accompanies normal aging.

In treating osteoporosis, many doctors have overlooked one of the most critical components for supporting healthy bone matrix: the trace mineral boron. Without boron, the absorption of calcium can be limited and often underutilized.1

Researchers have concluded that boron is an essential factor in facilitating the bone-building effects of key nutrients such as calcium, magnesium, and vitamin D. Numerous studies demonstrate boron is critical to maintaining and improving one’s bone health.1 Healthy bones, however, are just the beginning of the boron story.

In this article, we examine boron’s many health-promoting effects, which also include relieving joint pain associated with arthritis, reducing the risk of prostate cancer, preserving cognitive function, and relieving oxidative stress. Further, we examine how you can ensure that you are benefiting from the most advanced, bioavailable boron formulation available today.

Boron: An Often-Deficient Mineral

Boron is a trace mineral that is essential to plant growth and in turn finds its way into the human diet. Boron is present in plant foods such as fruits (especially plums, grapes, and avocados), vegetables, nuts, and legumes.

Despite its availability in nature, ingesting adequate amounts of boron can be difficult. For one thing, boron levels in plant foods are rather low.2 Moreover, modern dietary habits almost ensure boron deficiency, as many people do not eat nearly enough fruits and vegetables.

In the United States, estimated daily boron intake ranges from 0.5 mg to 3 mg, with 1 mg being average. Although there is no recommended dietary allowance for boron, evidence places the optimal daily boron intake at 2-3 mg daily (and higher).3 Ensuring optimal boron intake becomes increasingly important as we age, especially in light of boron’s critical role in safeguarding bone health. Further compounding the dangers of insufficient boron intake is that even well-informed adults who take boron supplements may not be getting the form of boron that supports optimal health and well-being.

A Superior Form of Boron

Boron’s demonstrated ability to strengthen bones and confer other important health benefits prompted scientists to seek out the most effective, bioavailable form of this critical element.

In researching various boron compounds, scientists discovered a plant form of boron known as calcium fructoborate, which is a complex of calcium, fructose, and boron found naturally in fruits, vegetables, and other foods.2 This innovative form of boron is not only safe and well tolerated, but has been shown to be much more bioavailable than other commercial forms of boron.2

This novel form of boron—known as FruiteX B® OsteoBoron™—is clearly the most advanced boron compound available today. One of the primary benefits of FruiteX B® OsteoBoron™ is that it is readily absorbed intact from the gastrointestinal tract and transported in the body as fructoborate, where it demonstrates high biological availability.2 FruiteX B® OsteoBoron™ is also highly stable, which enables it to remain in a usable form much longer in the body.2-5

Boron Is Essential to Bone Health

Ensuring healthy bones is fundamental to any anti-aging program, since weak bones can lead to disabling and even life-threatening bone fractures. Boron plays an integral part in bone metabolism, as it supports the functions of calcium, magnesium, and vitamin D, all of which are crucial to promoting dense, healthy bone tissue.6-9

In an important study of postmenopausal women who were not on estrogen replacement therapy, scientists examined boron’s effect on various measures of bone health. The subjects consumed a boron-deficient diet for 119 days, followed by 48 days of boron supplementation. On the boron-depleted diet, the women demonstrated increased urinary loss of both calcium and magnesium. On the boron-supplemented diet, however, they showed less urinary excretion of calcium and magnesium, as well as increased levels of two hormones associated with healthy bone mass.8 These findings indicate that adequate boron intake is essential to preserving the body’s stores of bone-building calcium and magnesium.

The researchers also studied the women during periods of both adequate magnesium intake and magnesium deficiency. Here, too, boron helped to preserve essential stores of calcium and magnesium in the body. While the magnesium-depleted diet was associated with increased loss of urinary calcium, boron supplementation significantly reduced urinary loss of both calcium and magnesium. The researchers observed that boron deprivation produced changes similar to those seen in osteoporosis, and that adequate boron status helped prevent calcium loss and bone demineralization in postmenopausal women.8 Boron thus has important applications in helping women preserve bone mass and prevent osteoporosis following menopause.

Boron may likewise help to alleviate the detrimental effects of vitamin D deficiency on calcium metabolism. Vitamin D is crucial to bone health because it helps to support calcium absorption. One study showed that when animals were fed a diet deficient in vitamin D, increasing dietary boron intake helped support optimal calcium absorption. This finding indicates an additional role for boron in promoting optimal mineral balance and ensuring healthy calcium utilization.9

Clinical studies demonstrate that FruiteX B® OsteoBoron™ is particularly effective in supporting healthy bones. One study confirmed the beneficial effects of FruiteX B® OsteoBoron™ on vitamin D status, a crucial contributor to bone health.2 In a pilot clinical study, 11 vitamin D-deficient patients were given 6 mg of boron from FruiteX B® OsteoBoron™ for 60 days. Ten of the 11 patients experienced an average 24% increase in serum vitamin D level, indicating that supplementation with FruiteX B® OsteoBoron™ may help optimize calcium metabolism and bone density.

Another study from the University of Wisconsin examined the effects of FruiteX B® OsteoBoron™ on vitamin D-deficient rats, which serve as a research model for studying osteoporosis treatments. After eight weeks of treatment with FruiteX B® OsteoBoron™, the rats’ bone mineral content increased by 5.8% compared to non-supplemented control animals. This finding lends additional weight to the beneficial role of FruiteX B® OsteoBoron™ in increasing bone mineral density.2

Remarkably, despite boron’s critical importance in maintaining bone health, some of the leading bone health products on the market—especially those containing calcium, vitamin D, and magnesium—do not include any form of boron! Furthermore, the few products that do include forms of boron that are not optimally absorbed. The absence of boron in bone health supplements may contribute to the epidemic of low bone mass and osteoporosis that afflicts so many aging adults, even those who use commercial supplements.

Boron Alleviates Osteoarthritis Pain

Osteoarthritis is the most common form of joint disease, a source of daily pain, stiffness, and decreased range of motion for millions of Americans. Emerging research indicates that, in addition to preserving bone health, boron may help relieve the debilitating symptoms of osteoarthritis.10

In one study involving subjects with osteoarthritis, 50% of the patients who received a daily supplement of 6 mg of boron noted less pain from movement, while only 10% of subjects given a placebo experienced similar improvement.11 As for the cause of this reduced pain, some studies indicate that boron-related biochemicals may decrease the production of pain-provoking inflammatory mediators.12-14

In another study, researchers observed that bones adjacent to joints with osteoarthritis tend to be less mineralized and have significantly lower concentrations of boron than do healthy bones. This finding suggests that low boron status may be associated with painful osteoarthritis, and again indicates an important role for boron in promoting healthy joint structure and function.15

Examining the relationship between boron intake and osteoarthritis prevalence around the world, researchers have uncovered epidemiological evidence demonstrating that in areas where boron intake is 1 mg or less per day, the estimated incidence of arthritis ranges from 20% to 70%. Conversely, in areas of the world where boron intake is usually 3-10 mg per day, the estimated incidence of arthritis is dramatically lower, ranging from zero to just 10%. This remarkable finding is compelling evidence that abundant intake of dietary boron may confer powerful protection against the development of osteoarthritis.16

Clinical studies demonstrate that FruiteX B® OsteoBoron™ is especially effective in managing the pain of osteoarthritis. An open-label pilot study conducted at the University of Novi Sad in Yugoslavia examined subjects with mild to severe osteoarthritis of the knees or hips, and utilized an osteoarthritis index that serves as a reliable tool for clinically evaluating new treatment agents. All patients completed the osteoarthritis questionnaire at the study’s onset and at four and eight weeks. The subjects were divided into two groups: those with mild or moderate osteoarthritis and those with severe osteoarthritis. The first group received 6 mg of boron from FruiteX B® OsteoBoron™ once a day for eight weeks, while the second received the same dose twice a day for eight weeks. Reductions in joint pain, stiffness, and inflexibility were reported by 79% of subjects in the first group and 59% of those in the second group.2 These important findings suggest that FruiteX B® OsteoBoron™ can help relieve mild to moderate arthritis pain, without the aid of pharmaceutical therapy.

Boron’s Role in Protecting Cognitive Function

Boron’s health benefits go beyond preserving bone and joint health while conferring protection against prostate cancer. This essential mineral may also have important applications in helping aging adults preserve one of their most treasured assets: cognitive function.20

Researchers investigated the effects of dietary boron intake on the cognitive performance of healthy older men and women.21 The participants were placed on a boron-deficient diet (containing approximately 0.25 mg of boron per 2,000 calories daily) and a diet with ample boron (containing approximately 3.25 mg of boron per 2,000 calories daily). Researchers assessed boron’s effects on various cognitive and psychomotor tests.

Compared to the high-boron diet, low dietary boron was correlated with markedly worse performance on tasks involving manual dexterity, hand-to-eye coordination, attention, perception, and short- and long-term memory. The researchers concluded that boron plays an important role in human brain function and cognitive performance, adding that the study findings strongly suggest that boron is an essential nutrient for human health.21

Boron Also Counters Oxidative Stress

In addition to boron’s beneficial effects on bone density, joint health, prostate cancer, and cognitive function, researchers have begun to explore its value as an antioxidant. The preliminary results are promising, indeed.

In a study at the University of Craiova in Romania, researchers investigated calcium fructoborate’s application in skin wounds and healing.22 Specifically, they tested whether calcium fructoborate exhibits antioxidant properties in human keratinocyte cultures, which serve as a laboratory model of human skin cells. Cells treated with calcium fructoborate were exposed to exogenous hydrogen peroxide to mimic environmentally induced oxidative stress. The researchers found that calcium fructoborate decreased the production of intracellular reactive oxygen species, leading them to conclude that calcium fructoborate has antioxidant activity that could have clinical significance in protecting skin cells from oxidation-induced injury.

Conclusion

Boron is emerging as a crucial nutrient for supporting healthy bone mass and thus avoiding the scourge of osteoporosis that plagues older Americans today. Compelling new evidence indicates that boron also promotes healthy joints, helps prevent prostate cancer, improves cognitive function, and may offer powerful antioxidant protection. This little-known mineral should be a nutritional staple for all seeking to optimize their health.

Recent research has found that not all boron formulations are equally effective. A newly available form of boron known as FruiteX B® OsteoBoron™ mimics the boron found in nature and demonstrates superior potency and bioavailability. This novel, advanced boron formulation should enable all health-conscious adults to take full advantage of boron’s broad array of health-promoting benefits.

ArthroMax™ with Theaflavins
120 vegetarian capsules
Item Catalog Number:
01317

As we age, structural alterations occur in our joints, leading to painful inflammation, discomfort, and loss of mobility. ArthroMax™ is the multi-nutrient formula designed to provide broad-spectrum support for aging joints and cartilage. And based on recent scientific findings, ArthroMax™ has been enhanced with higher potencies of certain ingredients and now also contains theaflavins.

This ArthroMax™ formula contains more glucosamine sulfate along with a special Boswellia extract known as 5-LOXIN®. Glucosamine sulfate provides underlying structural foundation for joints while 5-LOXIN® inhibits the 5-lipoxygenase enzyme, thereby reducing levels of pro-inflammatory leukotriene B4.

Inflammatory reactions are regulated by a series of cytokines produced in the body. Normal aging results in an unfavorable balance of cytokines that contributes to persistent inflammatory conditions. New studies have shown that a special fraction found in black tea suppresses pro-inflammatory cytokines at the genomic level. Scientists have found that these compounds called theaflavins uniquely down-regulate the expression of genes and cytokines associated with inflammatory conditions.36

ArthroMax™ provides these bioactive theaflavin fractions, along with methylsulfonylmethane (MSM), which contains sulfur components that are critically important in maintaining connective tissues such as tendons and cartilage. FruiteX B® OsteoBoron®, a patented form of boron identical to natural plant forms found in food and considered more bioavailable than other forms of boron, also supports healthy bones and joints.

ArthroMax™ with Theaflavins has less than 10 mg of caffeine per serving (the amount found in a quarter cup of brewed green tea).

Supplement Facts

Serving Size 4 capsules

Servings Per Container 30

Amount Per Serving

Glucosamine sulfate (as D-glucosamine sulfate 2KCl) (derived from corn)

2000 mg

Methylsulfonylmethane (MSM)

1000 mg

Black Tea (Camellia sinensis)

440 mg

Theaflavins Extract (leaf) [standardized to 12% TF2a fraction
(52.8 mg), along with TF-1, TF2b and TF3 theaflavin fractions]

5-LOXIN® [standardized for acetyl-11-keto-B-boswellic acid (AKBA) minimum 30% on dried basis (30 mg)]

100 mg

Boron (calcium fructoborate as patented FruiteX B® OsteoBoron™)

1.5 mg

Other ingredients: vegetable cellulose (capsule), magnesium stearate, silica.

Contains corn. This product contains NO milk, egg, fish, peanuts, crustacean shellfish (lobster, crab, shrimp) soybeans, tree nuts, wheat, yeast, gluten, or rice. Contains NO sugar, and no artificial sweeteners, flavors, colors, or preservatives.

5-LOXIN® is a registered trademark of P.L. Thomas & Co., Inc. U.S. Patents Pending.
FruiteX B® is a registered trademark and OsteoBoron™ is a trademark of VDF FutureCeuticals, Inc. U.S. Patent #5,962,049.


Dosage and Use
 

Take four capsules (two capsules in the morning and two capsules in the afternoon) with meals, or as recommended by a healthcare practitioner.

 

This supplement has less than 10 mg of caffeine per serving (the amount found in 1/4 cup of brewed green tea).


Warnings

Top References

1. Available at: http://www.merck.com/newsroom/press_releases/product/2004_0930.html. Accessed November 22, 2004.

2. Available at: http://www.rheumatology.org/annual/press. Accessed October 24, 2004.

3. Marsa M. What now for pain? With Vioxx off the market, consumers face tough decisions. Los Angeles Times. October 11, 2004:F1-F8.

4. Topol EJ. Failing the public health—rofecoxib, Merck, and the FDA. N Engl J Med. 2004 Oct 21;351(17):1707-9.

5. Cheng Y, Austin SC, Rocca B, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002 Apr 19;296(5567):539-41.

6. de Leval X, Hanson J, David JL, Masereel B, Pirotte B, Dogne JM. New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators. Curr Chem Med. 2004 May;11(10):1243-52.

7. Penglis PS, Cleland LG, Demasi M, Caughey GE, James MJ. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J Immunol. 2002 Aug 1;165(3):1605-11.

8. Rubinsztajn R, Wronska J, Chazan R. Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steriods anti-inflammatory drugs before and after oral aspirin challenge. Pol Arch Med Wewn. 2003 Aug;110(2):849-54.

9. Subbarao K, Jala VR, Mathis S, et al. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):369-75.

10. Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol. 2003 Sep;15(5):623-7.

11. Catella-Lawson F. Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. Neurology. 2001;57(5 Suppl 2):S5-7.

12. James MJ, Penglis PS, Caughey GE, Demasi M, Cleland LG. Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response? Inflamm Res. 2001 May;50(5):249-53.

13. Pommery N, Taverne T, Telliez A, et al. New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate can- cer chemotherapy. J Med Chem. 2004 Dec 2;47(25):6195-206.

14. Koehne CH, Dubois RN. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr;31(2 Suppl 7):12-21.

15. Abou-Issa H, Alshafie G. Celecoxib: a novel treatment for lung cancer. Expert Rev Anti-Cancer Ther. 2004 Oct;4(5):725-34.

16. Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women’s Health Institive. Cancer Res. 2003 Sep 15;63(18):6096-101.

17. Manav M, Su J, Hughes K, Lee HP, Ong CN. Omega-3 fatty acids and selenium as coronary heart disease risk modifying factors in Asian, Indian, and Chinese males. Nutrition. 2004 Nov:20(11-12):967-73.

18. Lugardon S, Lapeyre-Mestre M, Montastrue JL. Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Phamacovigilance Database. Eur J Clin Pharmacol. 2004 Nov;60(9):673-77.

19. Feldman M, Cryer B, Rushin K, Betancourt J. A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. Clin Appl Thromb Hemost. 2001 Jan;7(1):53-7.

20. Kiefer D. Quenching the flames of inflammatory brain aging. Life Extension. September, 2003.

21. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8(19):1695-706.

22. Walter MF, Jacob RF, Day CA, et al. Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. Atherosclerosis. 2004 Dec;177(2):235-43.

23. Available at: http://www.pfizer.com/are/news_releases/2004pr/mn_2004_1001.html. Accessed November 7, 2004.

24. Available at: http://www.money.cnn.com/2004/10/15/news/fortune500/pfizer. Accessed November 22, 2004.

25. Available at: http://biz.yahoo.com/ap/041018/pfizer_celebrex_study_11.html. Accessed November 22, 2004.

26. Available at: http://www.arthritis.org/resource4s/gettingstarted/default/asp. Accessed October 24, 2004.

27. Chan CC, Boyce S, Brideau C, et al. Rofecoxib [Vioxx, MK-0966; 4-(4’-methylsul fonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther. 1999 Aug;290(2):551-60.

28. Anonymous. Functional Assessment Resource Manual. Great Smokies Diagnostic Laboratory, Asheville, NC. Winter 2002:N41-N56.

29. Horrobin DF. Prostaglandin E1: physiological significance and clinical use. Wien Klin Wochenschr. 1988 Jul 15;100(14):471-7.

30. Ferretti A, Flanagan VP, Reeves VB. Occurrence of prostaglandin E3 in human urine as a result of marine oil ingestion: gas chromatographic-mass spectrometric evidence. Biochim Biophys Acta. 1988 Apr 15;959(3):262-8.

31. Mayatepek E, Paul K, Leichsenring M, et al. Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene B4 and prostaglandin E2 synthesis and course of experimental tuberculosis in guinea pigs. Infection. 1994 Mar;22(2):106-12.

32. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991 Sep;54(3):438- 63.

33. Hendler SS, Rorvik D. PDR for Nutritional Supplements, 1st Ed. Montvale, NJ: Medical Economics Co; 2001:149.

34. Manthey JA, Grohmann K, Montanari A, Ash K, Manthey CL. Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes. J Nat Prod. 1999 Mar;62(3):441-4.

35. Ishiwa J, Sato T, Mimaki Y, et al. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J Rheumatol. 2000 Jan;27(1):20- 5.

36. Lin N, Sato T, Takayama Y, et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol. 2003 Jun 15;65(12):2065-71.

37. Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkin- son’s disease. Neuroreport. 2001 Dec 4;12(17):3871-5.

38. Hendler SS, Rorvik D. PDR for Nutritional Supplements, 1st Ed. Montvale, NJ: Medical Economics Co; 2001:149.

39. Brandt KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med. 1987 Nov 20;83(5A):29-34.

40. Qiu GX, Gao SN, Giacovelli G, Rovati L, Setnikar I. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimit-telforschung. 1998 May;48(5):469-74.

41. Rizzo R, Grandolfo M, Godeas C, Jones KW, Vittur F. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study. J Exp Zool. 1995 Sep 1;273(1):82-6.

42. Murav'ev I, Venikova MS, Pleskovskaia GN, Riazantseva TA, Sigidin I. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter. 1991 Mar-Apr;(2):37-9.

43. Lawrence RM. Methysulfonylmethane (MSM): a double-blind study of its use in degenerative arthritis. Int J Anti-Aging Med. 1998;1:50.

44. Jacob SW, Lawrence RM, Zucker M. The Miracle of MSM. New York: Berkley Books, 1999.

45. Usha PR, Naidu MU. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmthane and their combination in osteoarthritis. Clin Drug Invest. 2004 Jun;24(6):353-63.

46. Takase B, Maruyama T, Kurita A, et al. Arachidonic acid metabolites in acute myocardial infarction. Angiology. 1996 Jul;47(7):649-61.

47. Foral PA, Nystrom KK, Wilson AF, Christensen CM. Gastrointestinal-related adverse effects of COX-2 inhibitors. Drugs Today. 2003 Dec;39(12):939-48.

48. Biancone L, Tosti C, Geremia A, et al. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. Aliment Pharmacol Ther. 2004 Apr 1;19(7):755-64.

Theaflavins

1. Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem. 2006 Sep;6(5):389-406.

2. Cameron AR, Anton S, Melville L, et al. Black tea polyphenols mimic insulin/insulin-like growth factor-1 signalling to the longevity factor FOXO1a. Aging Cell. 2008 Jan;7(1):69-77.

3. Yung LM, Leung FP, Wong WT, et al. Tea polyphenols benefit vascular function. Inflammopharmacology. 2008 Sep 26.

4. Benelli R, Vene R, Bisacchi D, Garbisa S, Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem. 2002 Jan;383(1):101-5.

5. Aneja R, Odoms K, Denenberg AG, Wong HR. Theaflavin, a black tea extract, is a novel anti-inflammatory compound. Crit Care Med. 2004 Oct;32(10):2097-103.

6. Kebschull M, Demmer R, Behle JH, et al. Granulocyte chemotactic protein 2 (gcp-2/cxcl6) complements interleukin-8 in periodontal disease. J Periodontal Res. 2008 Oct 7.

7. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflammation in COPD and asthma: similarities and differences. Nihon Kokyuki Gakkai Zasshi. 2008 Jun;46(6):443-7.

8. Bode AM, Dong Z. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 2000 Nov;1:181-8.

9. Lyn-Cook BD, Rogers T, Yan Y, et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer. 1999;35(1):80-6.

10. Chen YC, Liang YC, Lin-Shiau SY, Ho CT, Lin JK. Inhibition of TPA-induced protein kinase C and transcription activator protein-1 binding activities by theaflavin-3,3’-digallate from black tea in NIH3T3 cells. J Agric Food Chem. 1999 Apr;47(4):1416-21.

11. Lin YL, Tsai SH, Lin-Shiau SY, Ho CT, Lin JK. Theaflavin-3,3’-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. Eur J Pharmacol. 1999 Feb 19;367(2-3):379-88.

12. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK. Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3’-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol. 2000 Feb 15;59(4):357-67.

13. Liang YC, Tsai DC, Lin-Shiau SY, et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory skin edema and ornithine decarboxylase activity by theaflavin-3,3’-digallate in mouse. Nutr Cancer. 2002;42(2):217-23.

14. Lin JK. Cancer chemoprevention by tea polyphenols through modulating signal transduction pathways. Arch Pharm Res. 2002 Oct;25(5):561-71.

15. Sugatani J, Fukazawa N, Ujihara K, et al. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Int Arch Allergy Immunol. 2004 May;134(1):17-28.

16. Cai F, Li CR, Wu JL, et al. Theaflavin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1. Mediators Inflamm. 2006;2006(5):30490.

17. Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem. 2004 Feb 1;91(2):232-42.

18. Siddiqui IA, Raisuddin S, Shukla Y. Protective effects of black tea extract on testosterone induced oxidative damage in prostate. Cancer Lett. 2005 Sep 28;227(2):125-32.

19. Siddiqui IA, Zaman N, Aziz MH, et al. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis. 2006 Apr;27(4):833-9.

20. Zykova TA, Zhang Y, Zhu F, Bode AM, Dong Z. The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis. 2005 Feb;26(2):331-42.

21. Cai F, Li C, Wu J, et al. Modulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3’-gallate in the rats exposed to cerebral ischemia-reperfusion. Folia Biol (Praha). 2007;53(5):164-72.

22. Das D, Mukherjee S, Das AS, Mukherjee M, Mitra C. Aqueous extract of black tea (Camellia sinensis) prevents ethanol+cholecystokinin-induced pancreatitis in a rat model. Life Sci. 2006 Apr 4;78(19):2194-203.

23. Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3,3’-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol. 2006 Sep;149(1):121-31.

24. Banerjee S, Manna S, Saha P, Panda CK, Das S. Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev. 2005 Jun;14(3):215-21.

25. Banerjee S, Manna S, Mukherjee S, et al. Black tea polyphenols restrict benzopyrene-induced mouse lung cancer progression through inhibition of Cox-2 and induction of caspase-3 expression. Asian Pac J Cancer Prev. 2006 Oct;7(4):661-6.

26. Banerjee S, Maity P, Mukherjee S, et al. Black tea prevents cigarette smoke-induced apoptosis and lung damage. J Inflamm (Lond). 2007;43.

27. Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res. 2007 Jan 15;73(2):348-58.

28. Karori SM, Ngure RM, Wachira FN, Wanyoko JK, Mwangi JN. Different types of tea products attenuate inflammation induced in Trypanosoma brucei infected mice. Parasitol Int. 2008 Sep;57(3):325-33.

29. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003 Jun 23;163(12):1448-53.

30. Duffy SJ, Keaney JF, Jr., Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001 Jul 10;104(2):151-6.

31. Steptoe A, Gibson EL, Vuononvirta R, et al. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis. 2007 Aug;193(2):277-82.

32. Marjanovic JA, Stojanovic A, Brovkovych VM, Skidgel RA, Du X. Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J Biol Chem. 2008 Oct 24;283(43):28827-34.

33. Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol. 2008 Sep 1;181(5):3495-502.

34. Dordelmann C, Telgmann R, Brand E, et al. Functional and structural profiling of the human thrombopoietin gene promoter. J Biol Chem. 2008 Sep 5;283(36):24382-91.

35. Kalra N, Seth K, Prasad S, et al. Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci. 2007 May 16;80(23):2137-46.

36. Park AM, Dong Z. Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol. 2003 Jan 31;36(1):66-77.

37. Lin CL, Huang HC, Lin JK. Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res. 2007 Nov;48(11):2334-43.

38. Available at: http://www.medicalnewstoday.com/articles/67591.php. Accessed October 23, 2008.

39. WG0401 protective against generalized inflammation in a human study. Unpublished data, WellGen, Inc.; 2007.

40. McGuirk P, Higgins SC, Mills KH. Regulatory cells and the control of respiratory infection. Curr Allergy Asthma Rep. 2005 Jan;5(1):51-5.

41. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev. 2007 Dec;65(12 Pt 2):S173-6.

42. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev. 2007 Dec;65(12 Pt 2):S253-9.

43. Ordovas J. Diet/genetic interactions and their effects on inflammatory markers. Nutr Rev. 2007 Dec;65(12 Pt 2):S203-7.

44. Gillies PJ. Preemptive nutrition of pro-inflammatory states: a nutrigenomic model. Nutr Rev. 2007 Dec;65(12 Pt 2):S217-20.

45. Lindi V, Schwab U, Louheranta A, et al. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol Genet Metab. 2003 May;79(1):52-60.

46. Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res. 2008 Mar;40(3):199-205.

47. Blazovics A, Hagymasi K, Pronai L. Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases. Orv Hetil. 2004 Dec 12;145(50):2523-9.

48. Chen HW, Lee JY, Huang JY, et al. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res. 2008 Sep 15;68(18):7428-38.

49. Caramia G. Omega-3: from cod-liver oil to nutrigenomics. Minerva Pediatr. 2008 Aug;60(4):443-55.

50. Crujeiras AB, Parra D, Milagro FI, et al. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a Nutrigenomics Study. OMICS. 2008 Aug 7.

51. Fernandes G. Progress in nutritional immunology. Immunol Res. 2008;40(3):244-61.

52. Hall AJ, Babish JG, Darland GK, et al. Safety, efficacy and anti-inflammatory activity of rho iso-alpha-acids from hops. Phytochemistry. 2008 May;69(7):1534-47.

53. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol. 2008 Jun;19(3):242-7.

54. Kornman K, Rogus J, Roh-Schmidt H, et al. Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept. Nutrition. 2007 Nov;23(11-12):844-52.

55. Kussmann M, Blum S. OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers. Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):271-87.

56. Rimbach G, Boesch-Saadatmandi C, Frank J, et al. Dietary isoflavones in the prevention of cardiovascular disease—a molecular perspective. Food Chem Toxicol. 2008 Apr;46(4):1308-19.

Boron

1. Kelly GS. Boron: A review of its nutritional interactions and therapeutic uses. Altern Med Rev. 1997 Jan;2(1):48-56.

2. Available at: www.futureceuticals.com/proprietary/pdf/FruitexBBrochure.pdf. Accessed June 1, 2006.

3. Available at: www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/bor_0040.shtml. Accessed June 1, 2006.

4. Smyth HF Jr, Carpenter CP, Weil CS, Pozzani UC, Striegel JA, Nycum JS. Range-finding toxicity data: List VII. Am Ind Hyg Assoc J. 1969 Sep-Oct;30(5)470-6.

5. Available at: http://swpat.ffii.org/pikta/txt/ep/1001/788/. Accessed June 1, 2006.

6. Schaafsma A, de Vries PJ, Saris WH. Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr. 2001 May;41(4):225-49.

7. Miggiano GA, Gagliardi L. Diet, nutrition and bone health. Clin Ter. 2005 Jan-Apr;156(1-2):47-56.

8. Nielsen FH, Hunt CD, Mullen LM, Hunt JR. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women. FASEB J. 1987 Nov;1(5):394-7.

9. Hegsted M, Keenan MJ, Siver F, Wozniak P. Effect of boron on vitamin D deficient rats. Biol Trace Elem Res. 1991 Mar;28(3):243-55.

10. Gaby AR. Natural treatments for osteoarthritis. Altern Med Rev. 1999 Oct;4(5):330-41.

11. Travers RL, Rennie GC, Newnham RE. Boron and arthritis: the result of a double-blind pilot study. J Nutr Med. 1990;1:127–32.

12. Hall IH, Rajendran KG, Chen SY, et al. Anti-inflammatory activity of amine-carboxyboranes in rodents. Arch Pharm (Weinheim). 1995 Jan;328(1):39-44.

13. Rajendran KG, Chen SY, Sood A, Spielvogel BF, Hall IH. The anti-osteoporotic activity of amine-carboxyboranes in rodents. Biomed Pharmacother. 1995;49(3):131-40.

14. Hall IH, Starnes CO, McPhail AT, et al. Anti-inflammatory activity of amine cyanoboranes, amine carboxyboranes, and related compounds. J Pharm Sci. 1980 Sep;69(9):1025-9.

15. Helliwell TR, Kelly SA, Walsh HP, et al. Elemental analysis of femoral bone from patients with fractured neck of femur or osteoarthrosis. Bone. 1996 Feb;18(2):151-7.

16. Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.

17. Zhang Z-F, Winton MI, Rainey C, et al. Boron is associated with decreased risk of human prostate cancer. FASEB J. 2001;15:A1089.

18. Faloon W, Strum S. Does PSA promote prostate cancer? Life Extension. June, 2005: 7-13.

19. Gallardo-Williams MT, Chapin RE, King PE, et al. Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma(LNCaP) tumors in nude mice. Toxicol Pathol. 2004 Jan-Feb;32(1):73-8.

20. Penland JG. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998;66(1-3):299-317.

21. Penland JG. Dietary boron, brain function, and cognitive performance. Environ Health Perspect. 1994 Nov;102 Suppl 7:65-72.

22. Scorei R, Cimpoiasu VM, Iordachescu D. In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res. 2005 Nov;107(2):127-34.


 

Bottom References

Bone & Joint Health

1. Acta Obstet Gynecol Scand. 1993 Apr;72(3):148-56.
2. J Am Geriatr Soc. 2005 Nov;53(11):1875-80.
3. Scand J Rheumatol Suppl. 1994;100:9-19.
4. Magnes Trace Elem. 1990;9(2):61-9.
5. Curr Pharm Des. 2003;9(32):2687-704.
6. Magnes Res. 1993 Jun;6(2):155-63.
7. J Reprod Med. 1990 May;35(5):503-7.
8. Gynecol Endocrinol. 1994 Mar;8(1):55-8.
9. J Nutr. 1994 Jul;124(7):1060-4.
10. Bone. 2003 Feb;32(2):127-35.
11. Magnes Res. 1993 Sep;6(3):247-9.
12. Am J Clin Nutr. 1995 Mar;61(3 Suppl):638S-45S.
13. Am J Clin Nutr. 2007 Jul;86(1):251-9.
14. Clin Rehabil. 2007 Jun;21(6):523-34.
15. Arch Intern Med. 2006 Feb 27;166(4):424-30.
16. J Am Coll Nutr. 1993 Aug;12(4):384-9.
17. Ter Arkh. 2004;76(11):88-93.
18. J Clin Pharmacol. 1999 Nov;39(11):1151-4.
19. J Pharmacol Exp Ther. 2005 Jun;313(3):1217-22.
20. J Clin Pharmacol. 2000 Nov;40(11):1237-44.
21. FASEB J 1987 Nov;1(5):394-7.
22. J Clin Endocrinol Metab. 2006 Dec;91(12):4866-72.
23. Environ Health Perspect. 1994 Nov;102 Suppl 7:83-5.
24. Crit Rev Food Sci Nutr. 2003;43(2):219-31. Review.
25. Prog Food Nutr Sci. 1993 Oct-Dec;17(4):331-49. Review.
26. Mediators Inflamm. 2006;2006(5):30490.
27. Br J Sports Med. 2004 Aug;38(4):431-5.
28. Acta Chir Orthop Traumatol Cech. 2001;68(1):45-9.
29. Clin Immunol. 2008 Jul;128(1):66-74.
30. Int Immunopharmacol. 2004 Feb;4(2):255-64.
31. Immunol Invest. 2008;37(4):263-77.
32. J Assoc Physicians India. 2001 Jun;49:617-21.
33. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30.
34. Wien Med Wochenschr. 1999;149(21-22):577-80.
35. Clin Rheumatol. 2004 Oct;23(5):410-5.
36. Phytomedicine. 2002 Dec;9(8):681-6.
37. Eksp Klin Farmakol. 2002 Nov-Dec;65(6):67-9.
38. Fortschr Med. 1980 Jun 5;98(21):801-6.
39. Osteoarthritis Cartilage. 2003 Jun;11(6):424-32.
40. Osteoarthritis Cartilage. 1998 Nov;6(6):427-34.
41. Perit Dial Int. 2007 Jun;27 Suppl 2:S104-9.
42. Perit Dial Int. 2007 Jul-Aug;27(4):375-90.
43. Arthritis Res Ther. 2007;9(6):R117.
44. Evid Based Complement Alternat Med. 2007 Jun;4(2):219-24.
45. Arthritis Rheum. 2007 Feb;56(2):555-67.
46. Rheumatol Int. 2007 Jan;27(3):213-8.
47. N Engl J Med. 2006 Feb 23;354(8):795-808.
48. Biomaterials. 2001 Sep;22(17):2359-69.
49. Osteoarthritis Cartilage. 1998 May;6 Suppl A:39-46.
50. Osteoarthritis Cartilage. 1998 May;6 Suppl A:37-8.
51. Arthritis Rheum. 1988 Jan;31(1):63-71.
52. Osteoarthritis Cartilage. 2001 Jan;9(1):14-21.
53. Arzneimittelforschung. 1998 May;48(5):469-74.
54. Osteoarthritis Cartilage. 2003 Apr;11(4):290-8.
55. J Immunol. 2001 Apr 15;166(8):5155-60.
56. Arthritis Rheum. 1990 Apr;33(4):477-84.
57. Adv Immunol. 1997;64:283-350.


*Privacy Policy: Heart 2 Heart of America collects your name and email to send you up to date information through our free email newsletter. Any email inquires or information collected from this website will be used solely for communication purposes and will not be sold or transmitted to any third parties. If you choose to modify or delete your personal information or opt-out from receiving our email newsletter, please email support@heart2heartcorp.com

The information herein is not intended to replace the medical advice of your physician. You are advised to consult with your physician with regards to matters relating to your health, and in particular regarding matters that may require diagnosis or medical attention. DO NOT stop taking medications without first consulting with your physician. These statements have not been evaluated by the Food and Drug Administration.Every effort has been made to ensure that the information provided herein is accurate, up-to-date, and complete, but no guarantee is made to that effect. This information has been compiled for use by healthcare practitioners and consumers in the United States. Heart 2 Heart of America does not endorse drugs, diagnose patients or recommend therapy. This informational resource is designed to assist licensed healthcare practitioners in caring for their patients and/ or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. Heart 2 Heart of America does not assume any responsibility for any aspect of healthcare administered with the aid of information Heart 2 Heart of America compiles. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions, check with your doctor, nurse or pharmacist.